IKS Health and Certilytics have expanded their strategic partnership to utilize Agentic AI and Human-in-the-Loop oversight to close the historic divide between healthcare payers and providers. The collaboration focuses on turning predictive insights into safe, coordinated clinical actions. Key use cases include automating over 70% of prior authorization workflows, enhancing member engagement, and providing accurate consumer price transparency at the point of care. The announcement was made on March 24, 2026.
Expanded AI Collaboration Announced
IKS Health, a leader in care enablement solutions, and Certilytics, Inc., specializing in AI-driven healthcare intelligence, announced an expansion of their strategic partnership on March 24, 2026. The core objective of this expanded collaboration is to bridge the long-standing divide between healthcare payers and providers by translating predictive insights into safe, coordinated clinical actions.
As healthcare transitions into the era of agentic AI, the focus is shifting from mere identification of risks to the execution of necessary work. The integration combines Certilytics’ BrainstormAI® Studio and CertHLM™ with the IKS Health Agentic Care Enablement Platform, creating an ecosystem where AI agents manage complex tasks like prior authorization and patient outreach, all under continuous human oversight.
Key Strategic Focus Areas
The collaboration will initially center on three critical strategic use cases:
- Prior Authorization Transparency: Moving beyond generalized rules to real-time, payer-specific rule sets. This is projected to handle more than 70% of all prior authorization workflows autonomously, significantly reducing provider burden and speeding up patient care.
- Member Engagement: Scaling outreach efforts to become proactive clinical connections aimed at effectively closing care gaps, moving beyond simple notifications.
- Consumer Price Transparency: Ensuring that patients and employers receive accurate financial outlooks at the point of care, rather than weeks later.
Leadership Perspectives
Sachin K. Gupta, Founder and Global CEO of IKS Health, emphasized the importance of responsible AI application: “By expanding our partnership with Certilytics, we are connecting payer rules and provider workflows through predictive analytics with our proven human-in-the-loop model serving as the ultimate safeguard for clinical and administrative accuracy.”
Merle A. Ryland, CEO of Certilytics, highlighted the power of generative AI capabilities: “We are equally excited about this unique partnership with IKS Health to bring providers, health plans, payers, and plan sponsors together in making full use of the science and computing power of generative AI capabilities.”
Robert Dwyer, Ph.D., Chief Data Scientist of Certilytics, added that the joint teams have created “truly practical, readily deployable AI architected tools that we believe will deliver on the immense promise of this science.”
Company Background Notes
IKS Health, founded in 2006, is recognized by KLAS and Google Cloud for its performance and AI augmentation services. Inventurus Knowledge Solutions Limited, the listed entity, trades on the NSE (Symbol: IKS) and BSE (Scrip Code: 544309). Certilytics, Inc., focuses on health data and predictive analytics, utilizing its BrainstormAI® platform to drive cost savings and improved outcomes for payers and providers.
Source: BSE
